StocksF › FATE

Fate Therapeutics, Inc. (FATE) — Earnings Call X-Ray

Our AI read all 34 of FATE's earnings calls (2016–2024) and answered the same battery of questions about each one. Every past call is free; the newest quarter unlocks with a free account.

Latest Call Grade
🔒
Q1 2024 · sign up to see
Previous Call Grade
D
Q4 2023
Expected Move
🔒
next 45 days · members
Calls Analyzed
34
2016–2024
Avg Candor
6.2/9
evasion 3.4/9
Critic AmmunitionUnderused Fixed CostsMargins ContractingCutting HeadcountReads RehearsedQuestion Left HangingResults Worse Than Direction

Call-by-call analysis

🔒 Q1 2024 earnings call 2024-05-11 NEWEST

Guidance: ■■■■■Demand: ■■■■■■ Margins: ■■■■Backlog: ■■■■ ■ analysts, ■■ questionsexpected move ±■■%
Candor /9
Specificity /9
Evasion /9
Stress /9

Management ■■■■■■ guidance against ■■■■■■■■ demand and ■■■■■■■ margins. The delivery was ■■■■■■■■ and ■■■■ in specifics, with ■■■ questions left hanging.

🔒 The Q1 2024 call grade is ready
The full 37-point AI read of FATE's newest earnings call — grade, expected move, and every question answered — is free with an account.
Sign up free to unlock

D Q4 2023 earnings call 2024-02-26 move ±23.2%

Management gave no formal guidance against contracting margins. The delivery was rich in specifics.

Margins: contractingHeadcount: cuttingCapex: decreasing 11 analysts · 22 questions
⚑ Critic ammunition⚑ Question left hanging✓ Resolves doubts⚑ Reads rehearsedDirection beats results
Candor 6/9
Specificity 7/9
Evasion 3/9
Confidence 7/9
Uncertainty 5/9
Promotion 6/9
Stress 3/9
Complexity 8/9
All 20 questions our AI answered about this call
NO Would a skeptical short-seller find this call reassuring?
NO Would a careful investor underwrite management's guidance?
NO Is management's confidence proportionate to the evidence presented?
YES Does the call resolve more doubts than it creates?
YES Is there something a critic could fairly use against the company?
YES Is a claimed advantage dependent on scale they lack?
YES Does an obvious question remain unanswered?
NO Is a product early in its life but growing very fast?
YES Do they serve a small fraction of their addressable customers?
NO Is volume about to step up rather than grow gradually?
YES Are high fixed costs currently underutilised?
NO Is pricing recovering from a depressed level?
YES Do current results look bad while the direction looks better?
NO Are deferred revenue or customer prepayments growing?
NO Is consolidation happening among their peers?
NO Is a founder still running the company?
NO Does the final speaker sound like they are summarizing a finished story?
NO Is a fast-growing segment obscured by a declining one?
NO Does the CFO speak more than the CEO?
YES Does the call read rehearsed rather than lived?

D Q3 2023 earnings call 2023-11-08 move ±22.5%

Management held guidance steady against contracting margins. The delivery was rich in specifics.

Guidance: maintainedMargins: contractingHeadcount: cuttingCapex: decreasing 10 analysts · 17 questions
⚑ Critic ammunition⚑ Question left hanging✓ Guidance underwritableFounder-ledDirection beats results
Candor 6/9
Specificity 7/9
Evasion 4/9
Confidence 7/9
Uncertainty 5/9
Promotion 6/9
Stress 2/9
Complexity 8/9
All 20 questions our AI answered about this call
NO Would a skeptical short-seller find this call reassuring?
YES Would a careful investor underwrite management's guidance?
NO Is management's confidence proportionate to the evidence presented?
NO Does the call resolve more doubts than it creates?
YES Is there something a critic could fairly use against the company?
YES Is a claimed advantage dependent on scale they lack?
YES Does an obvious question remain unanswered?
NO Is a product early in its life but growing very fast?
YES Do they serve a small fraction of their addressable customers?
NO Is volume about to step up rather than grow gradually?
YES Are high fixed costs currently underutilised?
NO Is pricing recovering from a depressed level?
YES Do current results look bad while the direction looks better?
NO Are deferred revenue or customer prepayments growing?
NO Is consolidation happening among their peers?
YES Is a founder still running the company?
NO Does the final speaker sound like they are summarizing a finished story?
NO Is a fast-growing segment obscured by a declining one?
NO Does the CFO speak more than the CEO?
NO Does the call read rehearsed rather than lived?

D Q2 2023 earnings call 2023-08-08 move ±11.1%

Management held guidance steady against contracting margins. The delivery was rich in specifics.

Guidance: maintainedMargins: contractingHeadcount: cuttingCapex: decreasing 7 analysts · 9 questions
⚑ Critic ammunition⚑ Question left hanging✓ Guidance underwritable⚑ Reads rehearsedDirection beats results
Candor 6/9
Specificity 7/9
Evasion 3/9
Confidence 7/9
Uncertainty 5/9
Promotion 5/9
Stress 4/9
Complexity 8/9
All 20 questions our AI answered about this call
NO Would a skeptical short-seller find this call reassuring?
YES Would a careful investor underwrite management's guidance?
NO Is management's confidence proportionate to the evidence presented?
NO Does the call resolve more doubts than it creates?
YES Is there something a critic could fairly use against the company?
YES Is a claimed advantage dependent on scale they lack?
YES Does an obvious question remain unanswered?
NO Is a product early in its life but growing very fast?
YES Do they serve a small fraction of their addressable customers?
NO Is volume about to step up rather than grow gradually?
YES Are high fixed costs currently underutilised?
NO Is pricing recovering from a depressed level?
YES Do current results look bad while the direction looks better?
NO Are deferred revenue or customer prepayments growing?
NO Is consolidation happening among their peers?
NO Is a founder still running the company?
NO Does the final speaker sound like they are summarizing a finished story?
NO Is a fast-growing segment obscured by a declining one?
NO Does the CFO speak more than the CEO?
YES Does the call read rehearsed rather than lived?

F Q1 2023 earnings call 2023-05-03 move ±14.8%

Management held guidance steady against contracting margins. The delivery was frequently evasive.

Guidance: maintainedMargins: contractingHeadcount: cutting 13 analysts · 20 questions
⚑ Critic ammunition⚑ Question left hanging✓ Guidance underwritable⚑ Reads rehearsedDirection beats results
Candor 6/9
Specificity 6/9
Evasion 6/9
Confidence 6/9
Uncertainty 4/9
Promotion 5/9
Stress 3/9
Complexity 8/9
All 20 questions our AI answered about this call
NO Would a skeptical short-seller find this call reassuring?
YES Would a careful investor underwrite management's guidance?
NO Is management's confidence proportionate to the evidence presented?
NO Does the call resolve more doubts than it creates?
YES Is there something a critic could fairly use against the company?
NO Is a claimed advantage dependent on scale they lack?
YES Does an obvious question remain unanswered?
NO Is a product early in its life but growing very fast?
YES Do they serve a small fraction of their addressable customers?
NO Is volume about to step up rather than grow gradually?
YES Are high fixed costs currently underutilised?
NO Is pricing recovering from a depressed level?
YES Do current results look bad while the direction looks better?
NO Are deferred revenue or customer prepayments growing?
NO Is consolidation happening among their peers?
NO Is a founder still running the company?
NO Does the final speaker sound like they are summarizing a finished story?
NO Is a fast-growing segment obscured by a declining one?
NO Does the CFO speak more than the CEO?
YES Does the call read rehearsed rather than lived?

F Q4 2022 earnings call 2023-02-28 move ±11.6%

Management gave no formal guidance against contracting margins. The delivery was unusually candid.

Margins: contractingHeadcount: cuttingCapex: decreasing 12 analysts · 14 questions
⚑ Critic ammunition⚑ Question left hanging⚑ Reads rehearsedDirection beats results
Candor 7/9
Specificity 6/9
Evasion 4/9
Confidence 6/9
Uncertainty 5/9
Promotion 5/9
Stress 5/9
Complexity 8/9
All 20 questions our AI answered about this call
NO Would a skeptical short-seller find this call reassuring?
NO Would a careful investor underwrite management's guidance?
NO Is management's confidence proportionate to the evidence presented?
NO Does the call resolve more doubts than it creates?
YES Is there something a critic could fairly use against the company?
YES Is a claimed advantage dependent on scale they lack?
YES Does an obvious question remain unanswered?
NO Is a product early in its life but growing very fast?
YES Do they serve a small fraction of their addressable customers?
NO Is volume about to step up rather than grow gradually?
YES Are high fixed costs currently underutilised?
NO Is pricing recovering from a depressed level?
YES Do current results look bad while the direction looks better?
NO Are deferred revenue or customer prepayments growing?
NO Is consolidation happening among their peers?
NO Is a founder still running the company?
NO Does the final speaker sound like they are summarizing a finished story?
NO Is a fast-growing segment obscured by a declining one?
NO Does the CFO speak more than the CEO?
YES Does the call read rehearsed rather than lived?

D Q3 2022 earnings call 2022-11-03 move ±12.4%

Management raised guidance against contracting margins. The delivery was rich in specifics.

Guidance: raisedMargins: contractingHeadcount: growingCapex: increasing 9 analysts · 14 questions
⚑ Critic ammunition⚑ Question left hanging✓ Guidance underwritable⚑ Reads rehearsedDirection beats results
Candor 6/9
Specificity 7/9
Evasion 3/9
Confidence 7/9
Uncertainty 4/9
Promotion 6/9
Stress 2/9
Complexity 8/9
All 20 questions our AI answered about this call
NO Would a skeptical short-seller find this call reassuring?
YES Would a careful investor underwrite management's guidance?
NO Is management's confidence proportionate to the evidence presented?
NO Does the call resolve more doubts than it creates?
YES Is there something a critic could fairly use against the company?
YES Is a claimed advantage dependent on scale they lack?
YES Does an obvious question remain unanswered?
NO Is a product early in its life but growing very fast?
YES Do they serve a small fraction of their addressable customers?
NO Is volume about to step up rather than grow gradually?
YES Are high fixed costs currently underutilised?
NO Is pricing recovering from a depressed level?
YES Do current results look bad while the direction looks better?
NO Are deferred revenue or customer prepayments growing?
NO Is consolidation happening among their peers?
NO Is a founder still running the company?
NO Does the final speaker sound like they are summarizing a finished story?
NO Is a fast-growing segment obscured by a declining one?
NO Does the CFO speak more than the CEO?
YES Does the call read rehearsed rather than lived?

D Q2 2022 earnings call 2022-08-04 move ±13.4%

Management held guidance steady against contracting margins. The delivery was promotional in tone.

Guidance: maintainedMargins: contractingHeadcount: growingCapex: increasing 10 analysts · 17 questions
⚑ Critic ammunition⚑ Question left hanging✓ Guidance underwritable⚑ Reads rehearsedFounder-ledDirection beats results
Candor 6/9
Specificity 6/9
Evasion 4/9
Confidence 7/9
Uncertainty 4/9
Promotion 7/9
Stress 2/9
Complexity 8/9
All 20 questions our AI answered about this call
NO Would a skeptical short-seller find this call reassuring?
YES Would a careful investor underwrite management's guidance?
NO Is management's confidence proportionate to the evidence presented?
NO Does the call resolve more doubts than it creates?
YES Is there something a critic could fairly use against the company?
YES Is a claimed advantage dependent on scale they lack?
YES Does an obvious question remain unanswered?
NO Is a product early in its life but growing very fast?
YES Do they serve a small fraction of their addressable customers?
NO Is volume about to step up rather than grow gradually?
YES Are high fixed costs currently underutilised?
NO Is pricing recovering from a depressed level?
YES Do current results look bad while the direction looks better?
NO Are deferred revenue or customer prepayments growing?
NO Is consolidation happening among their peers?
YES Is a founder still running the company?
NO Does the final speaker sound like they are summarizing a finished story?
NO Is a fast-growing segment obscured by a declining one?
NO Does the CFO speak more than the CEO?
YES Does the call read rehearsed rather than lived?

Earlier calls

CallDateGradeGuidanceDemandMarginsCandorEvasion
Q1 2022 2022-05-04 D maintainedunclearcontracting 6/9 3/9
Q4 2021 2022-02-28 D noneunclearunclear 6/9 4/9
Q3 2021 2021-11-05 D noneacceleratingcontracting 6/9 4/9
Q2 2021 2021-08-04 D noneunclearcontracting 6/9 3/9
Q1 2021 2021-05-05 D noneunclearcontracting 6/9 4/9
Q4 2020 2021-02-25 C noneunclearcontracting 6/9 3/9
Q3 2020 2020-11-06 D noneunclearcontracting 7/9 3/9
Q2 2020 2020-08-05 D noneunclearcontracting 6/9 3/9
Q1 2020 2020-05-12 D noneunclearcontracting 7/9 3/9
Q4 2019 2020-03-03 D noneunclearcontracting 6/9 3/9
Q3 2019 2019-11-05 D noneunclearcontracting 6/9 3/9
Q2 2019 2019-08-06 C noneunclearcontracting 7/9 2/9
Q1 2019 2019-05-07 D noneunclearcontracting 6/9 4/9
Q4 2018 2019-03-05 D nonestablecontracting 6/9 3/9
Q3 2018 2018-11-02 D noneunclearcontracting 6/9 3/9
Q2 2018 2018-08-06 D noneunclearcontracting 7/9 4/9
Q1 2018 2018-05-10 C+ noneunclearcontracting 7/9 2/9
Q4 2017 2018-03-05 D noneunclearcontracting 6/9 3/9
Q3 2017 2017-11-02 D maintainedunclearcontracting 6/9 4/9
Q2 2017 2017-08-15 D noneunclearcontracting 6/9 4/9
Q1 2017 2017-05-15 C noneunclearcontracting 6/9 1/9
Q4 2016 2017-03-16 F noneunclearunclear 6/9 5/9
Q3 2016 2016-11-07 C noneunclearcontracting 6/9 2/9
Q2 2016 2016-08-08 D noneunclearcontracting 5/9 3/9
Q1 2016 2016-05-09 D noneunclearcontracting 6/9 5/9
Q4 2015 2016-03-03 C+ noneunclearcontracting 7/9 2/9

Research question bank — earlier calls

During our 1,600-question research program, batches of experimental hypotheses were tested directly against some of FATE's earlier calls. The YES answers — the rare hits — are shown; click any question to see every company that matched it. Full list: the question bank.

C Q3 2016 earnings call 2016-11-07

333 more research questions answered NO

How to read this page

The grade is a transparent composite of call quality — candor, specificity, low evasion, low stress, whether the call resolves more doubts than it creates, and the guidance action — not a buy or sell signal. The expected move is a volatility estimate from the one signal that survived our out-of-sample tests: how a stock's own reaction and pre-call volatility predict the size (not direction) of its next move. Full detail, including everything that failed: methodology.

Companies with similar call quality

AAC · AAC Holdings'AACAY · AAC Technologies HoldingAACG · ATA Creativity GlobalAADI · Aadi Bioscience, Inc.AALBF · Aalberts N.V.AAOI · Applied Optoelectronics,

FAT   All “F” companies    FATH

Not investment advice. Artul.ai publishes AI-generated earnings-call quality grades and expected-volatility estimates — never buy or sell recommendations. We tested over 1,600 predictive hypotheses against 165,000 transcripts; the honest result, including what failed, is documented in our methodology.